Search Results - "FICHTNER, I"

Refine Results
  1. 1

    SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival by Schmid, F, Wang, Q, Huska, M R, Andrade-Navarro, M A, Lemm, M, Fichtner, I, Dahlmann, M, Kobelt, D, Walther, W, Smith, J, Schlag, P M, Stein, U

    Published in Oncogene (17-11-2016)
    “…MACC1 (metastasis associated in colon cancer 1) is a prognostic biomarker for tumor progression, metastasis and survival of a variety of solid cancers…”
    Get full text
    Journal Article
  2. 2

    Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer by Sack, Ulrike, Walther, Wolfgang, Scudiero, Dominic, Selby, Mike, Kobelt, Dennis, Lemm, Margit, Fichtner, Iduna, Schlag, Peter M., Shoemaker, Robert H., Stein, Ulrike

    “…Background Metastasis formation in colon cancer severely reduces the survival rate in patients. S100A4, a calcium-binding protein, is implicated in promoting…”
    Get full text
    Journal Article
  3. 3

    Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo by Gajer, J M, Furdas, S D, Gründer, A, Gothwal, M, Heinicke, U, Keller, K, Colland, F, Fulda, S, Pahl, H L, Fichtner, I, Sippl, W, Jung, M

    Published in Oncogenesis (New York, NY) (01-02-2015)
    “…We have previously described novel histone acetyltransferase (HAT) inhibitors that block neuroblastoma cell growth in vitro . Here we show that two selected…”
    Get full text
    Journal Article
  4. 4

    Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies by Diaz Miqueli, A, Rolff, J, Lemm, M, Fichtner, I, Perez, R, Montero, E

    Published in British journal of cancer (24-03-2009)
    “…As epidermal growth factor receptor (EGFR) has been reported to be a radiation response modulator, HER inhibitors are regarded to act as potential…”
    Get full text
    Journal Article
  5. 5

    Mouse models for translational preclinical research in immuno-oncology by Wulf-Goldenberg, A, Stecklum, M, Reiner, Z, Fichtner, I, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of the study conducted by Wulf-Golderberg et al focusing the use mouse models for translational preclinical research in immuno-oncology is…”
    Get full text
    Journal Article
  6. 6

    New preclinical models for neuro-oncology: Orthotopic patient-derived glioblastoma xenografts in mice by Orthmann, A, Haybäck, J, Jödicke, A, Kuhn, S, Linnebacher, M, Fichtner, I, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of the study conducted by Orthmann et al initiating the development of a preclinical models for neuro-oncology, orthotopic patient-dericed…”
    Get full text
    Journal Article
  7. 7

    Preclinical models of patient derived xenografts (PDX) for immuno-oncology research by Stecklum, M, Wulf-Goldenberg, A, Brzezicha, B, Fichtner, I, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of the study conducted by Stecklum et al determining PD-L1 expression as a target for immunotherapy on different tumor cell lines and PDX and…”
    Get full text
    Journal Article
  8. 8

    INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model by Graeser, R., Esser, N., Unger, H., Fichtner, I., Zhu, A., Unger, C., Kratz, F.

    Published in Investigational new drugs (01-02-2010)
    “…Summary The (6-maleimidocaproyl)hydrazone derivative of doxorubicin (INNO-206) is an albumin-binding prodrug of doxorubicin with acid-sensitive properties that…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas by Fichtner, I., Slisow, W., Gill, J., Becker, M., Elbe, B., Hillebrand, T., Bibby, M.

    Published in European journal of cancer (1990) (01-01-2004)
    “…Despite some success in the treatment of colorectal carcinomas, novel rational therapies targeting specific cancer-related molecules are under development and…”
    Get full text
    Journal Article
  11. 11

    Evaluation of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts (PDX) by Rivera, M, Hoffmann, J, Wulf-Goldenberg, A, Schlag, P.M, Merk, J, Walther, W, Fichtner, I

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of a study by Rivera et al evaluating of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts…”
    Get full text
    Journal Article
  12. 12

    Molecular subtypes of head and neck cancer predict response to cetuximab treatment by Klinghammer, K, Otto, R, Raguse, J.D, Albers, A, Fichtner, I, Keilholz, U, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of the study conducted by Klinghammer et al establishing different molecular subtypes of head and neck cancer based on gene expression patterns as…”
    Get full text
    Journal Article
  13. 13

    Patient-derived xenografts (PDX) from agressive haematological malignancies by Brzezicha, B, Siegert, A, Walther, W, Fichtner, I, Hoffmann, J, Karawajew, L, Schmitt, C, Janz, M

    Published in European journal of cancer (1990) (01-12-2016)
    “…Aggressive B-cell lymphomas and acute myeloid leukaemia's (AML) constitute a substantial proportion of human haematological malignancies and pose an important…”
    Get full text
    Journal Article
  14. 14

    Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts by Rolff, J., Becker, M., Merk, J., Hoffmann, J., Fichtner, I.

    Published in Targeted oncology (01-08-2016)
    “…Background The differential outcomes of clinical studies of the targeted therapies for non-small cell lung cancer (NSCLC) indicate that better stratification…”
    Get full text
    Journal Article
  15. 15

    Impact of intratumoral heterogeneity of renal cancer on drug response and development of resistance in patient derived xenografts by Zeisig, R, Flechsig, S, Wulf-Goldenberg, A, Schmees, C, Jandrig, B, Hennenlotter, J, Bedke, J, Stenzl, A, Schostak, M, Becker, M, Fichtner, I, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…Background: Patients with advanced renal cell carcinoma (RCC) have a poor prognosis due to fast onset of resistance towards Standard of Care (SoC) drugs…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    PO-218 Cytokine-transgenic NOG mice engrafted with human peripheral blood cells support natural killer cell expansion by Paterka, M, Volden, P, Tanaka, A, Gimnopoulos, D, Fichtner, I

    Published in ESMO open (01-07-2018)
    “…IntroductionGiven the central role natural killer (NK) cells exert in immune responses and the great therapeutic potential they hold due to their ability to…”
    Get full text
    Journal Article
  19. 19

    Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems by BECKER, M, NITSCHE, A, NEUMANN, C, AUMANN, J, JUNGHAHN, I, FICHTNER, I

    Published in British journal of cancer (18-11-2002)
    “…The sensitive detection of human cells in immunodeficient rodents is a prerequisite for the monitoring of micrometastasis of solid tumours, dissemination of…”
    Get full text
    Journal Article
  20. 20

    Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo by BANNON, J. H, FICHTNER, I, O'NEILL, A, PAMPILLON, C, SWEENEY, N. J, STROHFELDT, K, WATSON, R. W, TACKE, M, MC GEE, M. M

    Published in British journal of cancer (05-11-2007)
    “…Titanocene compounds are a novel series of agents that exhibit cytotoxic effects in a variety of human cancer cells in vitro and in vivo. In this study, the…”
    Get full text
    Journal Article